About Nucleolar complex protein 4 homolog
Nucleolar complex protein 4 homolog (NOC4L) is a protein
from Homo sapiens identified by UniProt accession
Q9BVI4, 516 residues long.
MolForge cross-references it against 0 known binders and
28 disease associations.
Target properties
| Protein name | Nucleolar complex protein 4 homolog |
| UniProt accession | Q9BVI4 |
| Gene | NOC4L |
| Organism | Homo sapiens |
| Length | 516 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (28)
Diseases linked to this target (Open Targets).
- lysosomal storage disease · score 0.46
- Alzheimer disease · score 0.46
- neurodegenerative disease · score 0.46
- Parkinson disease · score 0.46
- multiple sclerosis · score 0.46
- mean corpuscular volume · score 0.21
- alcohol drinking · score 0.15
- body height · score 0.14
- lean body mass · score 0.13
- sitting height measurement · score 0.13
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9BVI4-F1 | alphafold | PREDICTED | 89.42 | — |
Amino-acid sequence (516 residues)
MEREPGAAGV RRALGRRLEA VLASRSEANA VFDILAVLQS EDQEEIQEAV RTCSRLFGAL LERGELFVGQ LPSEEMVMTG SQGATRKYKV WMRHRYHSCC NRLGELLGHP SFQVKELALS ALLKFVQLEG AHPLEKSKWE GNYLFPRELF KLVVGGLLSP EEDQSLLLSQ FREYLDYDDT RYHTMQAAVD AVARVTGQHP EVPPAFWNNA FTLLSAVSLP RREPTVSSFY VKRAELWDTW KVAHLKEHRR VFQAMWLSFL KHKLPLSLYK KVLLIVHDAI LPQLAQPTLM IDFLTRACDL GGALSLLALN GLFILIHKHN LEYPDFYRKL YGLLDPSVFH VKYRARFFHL ADLFLSSSHL PAYLVAAFAK RLARLALTAP PEALLMVLPF ICNLLRRHPA CRVLVHRPHG PELDADPYDP GEEDPAQSRA LESSLWELQA LQRHYHPEVS KAASVINQAL SMPEVSIAPL LELTAYEIFE RDLKKKGPEP VPLEFIPAQG LLGRPGELCA QHFTLS
Explore Nucleolar complex protein 4 homolog with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets